Syndax Pharmaceuticals (SNDX) Tops Q1 EPS by 14c

Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q1 EPS of ($0.85), $0.14 better than the analyst estimate of ($0.99).

For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Waste stocks ride AI and healthcare boom as CLH surges 27%
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen